Cargando…

Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine

BACKGROUND: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. METHODS: We examined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Chao, Zhang, Ji-chun, Yao, Wei, Ren, Qian, Ma, Min, Yang, Chun, Chaki, Shigeyuki, Hashimoto, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408970/
https://www.ncbi.nlm.nih.gov/pubmed/27765808
http://dx.doi.org/10.1093/ijnp/pyw089
_version_ 1783232391105478656
author Dong, Chao
Zhang, Ji-chun
Yao, Wei
Ren, Qian
Ma, Min
Yang, Chun
Chaki, Shigeyuki
Hashimoto, Kenji
author_facet Dong, Chao
Zhang, Ji-chun
Yao, Wei
Ren, Qian
Ma, Min
Yang, Chun
Chaki, Shigeyuki
Hashimoto, Kenji
author_sort Dong, Chao
collection PubMed
description BACKGROUND: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. METHODS: We examined the effects of MGS0039 (1 mg/kg) and ketamine (10 mg/kg) on depression-like behavior in susceptible mice after repeated social defeat stress. Protein levels of brain-derived neurotrophic factor, TrkB, phospho-TrkB, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (GluA1), postsynaptic density protein 95, and dendritic spine density in selected brain regions were measured. RESULTS: In the tail suspension and forced swimming tests, both MGS0039 and ketamine significantly attenuated the increased immobility time observed in susceptible mice, compared with vehicle-treated animals, 1 or 2 days after a single dose of drug. In the sucrose preference test, both compounds significantly improved the reduced preference typically seen in susceptible mice at 3 to 7 days after a single dose of drug. Western-blot analyses showed that similar to ketamine, MGS0039 significantly attenuated the reduced brain-derived neurotrophic factor, phospho-TrkB/TrkB ratio, GluA1 and postsynaptic density protein 95 seen in the prefrontal cortex, dentate gyrus, and CA3 of the hippocampus from susceptible mice, 8 days after a single dose. Again, in a similar manner to ketamine, MGS0039 significantly attenuated the reduction of spine density in the prelimbic regions of the medial prefrontal cortex, dentate gyrus, and CA3 of the hippocampus, but not infralimbic regions of the medial prefrontal cortex and CA1, in susceptible mice 8 days after a single dose. In contrast, neither drug elicited an effect on altered brain-derived neurotrophic factor-TrkB signaling, GluA1, and postsynaptic density protein 95 levels and did not increase spine density observed in the nucleus accumbens of susceptible mice. CONCLUSIONS: Similar to ketamine, MGS0039 shows rapid and sustained antidepressant effects in the social defeat stress model. Long-lasting synaptogenesis in the prelimbic regions of medial prefrontal cortex, dentate gyrus, and CA3 might be implicated in this sustained antidepressant effect.
format Online
Article
Text
id pubmed-5408970
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54089702017-05-03 Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine Dong, Chao Zhang, Ji-chun Yao, Wei Ren, Qian Ma, Min Yang, Chun Chaki, Shigeyuki Hashimoto, Kenji Int J Neuropsychopharmacol Regular Research Article BACKGROUND: Similar to the N-methyl-D-aspartate receptor antagonist ketamine, the metabotropic glutamate 2/3 receptor antagonist, MGS0039, shows antidepressant effects. However, there are no reports comparing these 2 compounds in the social defeat stress model of depression. METHODS: We examined the effects of MGS0039 (1 mg/kg) and ketamine (10 mg/kg) on depression-like behavior in susceptible mice after repeated social defeat stress. Protein levels of brain-derived neurotrophic factor, TrkB, phospho-TrkB, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (GluA1), postsynaptic density protein 95, and dendritic spine density in selected brain regions were measured. RESULTS: In the tail suspension and forced swimming tests, both MGS0039 and ketamine significantly attenuated the increased immobility time observed in susceptible mice, compared with vehicle-treated animals, 1 or 2 days after a single dose of drug. In the sucrose preference test, both compounds significantly improved the reduced preference typically seen in susceptible mice at 3 to 7 days after a single dose of drug. Western-blot analyses showed that similar to ketamine, MGS0039 significantly attenuated the reduced brain-derived neurotrophic factor, phospho-TrkB/TrkB ratio, GluA1 and postsynaptic density protein 95 seen in the prefrontal cortex, dentate gyrus, and CA3 of the hippocampus from susceptible mice, 8 days after a single dose. Again, in a similar manner to ketamine, MGS0039 significantly attenuated the reduction of spine density in the prelimbic regions of the medial prefrontal cortex, dentate gyrus, and CA3 of the hippocampus, but not infralimbic regions of the medial prefrontal cortex and CA1, in susceptible mice 8 days after a single dose. In contrast, neither drug elicited an effect on altered brain-derived neurotrophic factor-TrkB signaling, GluA1, and postsynaptic density protein 95 levels and did not increase spine density observed in the nucleus accumbens of susceptible mice. CONCLUSIONS: Similar to ketamine, MGS0039 shows rapid and sustained antidepressant effects in the social defeat stress model. Long-lasting synaptogenesis in the prelimbic regions of medial prefrontal cortex, dentate gyrus, and CA3 might be implicated in this sustained antidepressant effect. Oxford University Press 2016-10-08 /pmc/articles/PMC5408970/ /pubmed/27765808 http://dx.doi.org/10.1093/ijnp/pyw089 Text en © The Author 2016. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Regular Research Article
Dong, Chao
Zhang, Ji-chun
Yao, Wei
Ren, Qian
Ma, Min
Yang, Chun
Chaki, Shigeyuki
Hashimoto, Kenji
Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
title Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
title_full Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
title_fullStr Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
title_full_unstemmed Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
title_short Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
title_sort rapid and sustained antidepressant action of the mglu2/3 receptor antagonist mgs0039 in the social defeat stress model: comparison with ketamine
topic Regular Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408970/
https://www.ncbi.nlm.nih.gov/pubmed/27765808
http://dx.doi.org/10.1093/ijnp/pyw089
work_keys_str_mv AT dongchao rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT zhangjichun rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT yaowei rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT renqian rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT mamin rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT yangchun rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT chakishigeyuki rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine
AT hashimotokenji rapidandsustainedantidepressantactionofthemglu23receptorantagonistmgs0039inthesocialdefeatstressmodelcomparisonwithketamine